"Founded in 1866 as the Hebrew Hospital and Asylum, Sinai Hospital of Baltimore is a Jewish-sponsored health care organization providing care for all people. It is a nonprofit institution with a mission of providing quality patient care, teaching and research. Sinai is an agency of THE ASSOCIATED: Jewish Community Federation of Baltimore. Sinai Hospital of Baltimore provides a broad array of high quality, cost-effective health and health-related services to the people of greater Baltimore."

During the past decade, Sinai Hospital of Baltimore conducted 145 clinical trials. In the 10-year time frame, 145 clinical trials started and 148 clinical trials were completed, i.e. on average, 102.1% percent of trials that started reached the finish line to date. In the past 5 years, 48 clinical trials started and 72 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sinai Hospital of Baltimore" #1 sponsor was "National Cancer Institute (NCI)" with 98 trials, followed by "Children's Oncology Group" with 86 trials sponsored, "Radiation Therapy Oncology Group" with 30 trials sponsored, "SWOG Cancer Research Network" with 19 trials sponsored and "Alliance for Clinical Trials in Oncology" with 19 trials sponsored. Other sponsors include 120 different institutions and companies that sponsored additional 80 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sinai Hospital of Baltimore" #1 collaborator was "National Cancer Institute (NCI)" with 167 trials as a collaborator, "NRG Oncology" with 22 trials as a collaborator, "Children's Oncology Group" with 7 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator and "NCIC Clinical Trials Group" with 4 trials as a collaborator. Other collaborators include 96 different institutions and companies that were collaborators in the rest 87 trials.

According to Clinical.Site data, the most researched conditions in "Sinai Hospital of Baltimore" are "Recurrent Neuroblastoma" (22 trials), "Recurrent Osteosarcoma" (19 trials), "Refractory Neuroblastoma" (15 trials), "Recurrent Malignant Solid Neoplasm" (14 trials) and "Refractory Malignant Solid Neoplasm" (14 trials). Many other conditions were trialed in "Sinai Hospital of Baltimore" in a lesser frequency.

Most popular intervention types in "Sinai Hospital of Baltimore" are "Drug" (269 trials), "Other" (174 trials), "Biological" (108 trials), "Radiation" (81 trials) and "Procedure" (80 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (104 trials), "Cyclophosphamide" (40 trials), "Quality-of-Life Assessment" (38 trials), "Questionnaire Administration" (37 trials) and "radiation therapy" (32 trials). Other intervention names were less common.

The vast majority of trials in "Sinai Hospital of Baltimore" are 321 trials for "All" genders, 45 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "Sinai Hospital of Baltimore". 1 are not yet recruiting, 55 are recruiting, 102 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 167 completed trials in Sinai Hospital of Baltimore, 3 suspended trials, and 22 terminated clinical trials to date.

Out of the total trials that were conducted in Sinai Hospital of Baltimore, 20 "Phase 1" clinical trials were conducted, 136 "Phase 2" clinical trials and 168 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 28 trials that are defined as “Not Applicable".